The IBD SmartSelect Composite Rating for Nutanix rose from 94 to 96 Friday. Additionally, it sports a 97 Relative Strength number, but a mostly flat RS Line.
The new rating shows the stock is outpacing 96% of all stocks when it comes to the most important stock-picking criteria.
Nutanix is now out of buy range after clearing the 33.73 entry in a consolidation several months ago. Current action has been choppy, so let's see if can form a new pattern with a clear entry point.
See How IBD Helps You Make More Money In Stocks
The stock has an 81 EPS Rating, which means its recent quarterly and longer-term annual earnings growth is outpacing 81% of all stocks.
Its Accumulation/Distribution Rating of B shows moderate buying by institutional investors over the last 13 weeks.
NTNX Earnings Preview
The company reported 867% earnings growth for Q1. Revenue growth came in at 18%, down from 28% in the prior quarter. The company's next quarterly report is expected on or around Feb. 28.
Nutanix Stock holds the No. 13 rank among its peers in the Computer Software-Enterprise industry group. Salesforce, Datadog and ServiceNow are among the top 5 highly-rated stocks within the group.
Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks
